CAVALLARO, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 1.481
NA - Nord America 923
AS - Asia 654
OC - Oceania 15
SA - Sud America 15
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.102
Nazione #
US - Stati Uniti d'America 908
SE - Svezia 633
IT - Italia 390
SG - Singapore 286
CN - Cina 261
RU - Federazione Russa 187
FI - Finlandia 51
DE - Germania 49
IE - Irlanda 47
GB - Regno Unito 38
IN - India 28
HK - Hong Kong 16
ES - Italia 13
FR - Francia 13
NL - Olanda 13
AU - Australia 12
KR - Corea 12
CA - Canada 11
TR - Turchia 11
IR - Iran 10
BE - Belgio 9
DK - Danimarca 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
BR - Brasile 4
CH - Svizzera 4
EG - Egitto 4
ID - Indonesia 4
TW - Taiwan 4
AR - Argentina 3
AT - Austria 3
CO - Colombia 3
EC - Ecuador 3
GR - Grecia 3
MX - Messico 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
HR - Croazia 2
HU - Ungheria 2
LY - Libia 2
PE - Perù 2
PK - Pakistan 2
PL - Polonia 2
RO - Romania 2
RS - Serbia 2
SC - Seychelles 2
TH - Thailandia 2
TN - Tunisia 2
AZ - Azerbaigian 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
EU - Europa 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
KH - Cambogia 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 3.102
Città #
Lawrence 213
Princeton 213
Singapore 177
Shanghai 129
Milan 94
Moscow 75
Ashburn 64
New York 49
Helsinki 48
Dublin 46
Boardman 41
Rome 41
Pittsburgh 17
Pune 16
Beijing 14
Guangzhou 14
Dallas 13
Los Angeles 13
Genoa 12
Seattle 11
Washington 10
Ankara 6
Dalton 6
Frankfurt am Main 6
Freiburg im Breisgau 6
Phoenix 6
Turin 6
Bari 5
Brussels 5
Burnley 5
Central 5
Council Bluffs 5
Ferrara 5
Hong Kong 5
Jiaxing 5
Santander 5
Amsterdam 4
Borås 4
Cairo 4
Chongqing 4
Fortaleza 4
Gijang-gun 4
Istanbul 4
Malang 4
Messina 4
Mountain View 4
Padova 4
Perth 4
Pescara 4
Quincy 4
San Francisco 4
Secaucus 4
Shenzhen 4
Southwark 4
Verona 4
Adelaide 3
Ajman 3
Appleton 3
Bergamo 3
Blacksburg 3
Buccinasco 3
Calusco D'adda 3
Castiglion Fiorentino 3
Cosenza 3
Córdoba 3
Dubai 3
Eastern 3
Frederiksberg 3
Ghent 3
Guimarães 3
Guwahati 3
Hanover 3
Kolkata 3
Parma 3
Quito 3
Reggio Calabria 3
Rotterdam 3
Seocho-gu 3
Shiraz 3
Travaco Siccomario 3
Vienna 3
Wuxi 3
Xi'an 3
Albacete 2
Auckland 2
Aversa 2
Azzano San Paolo 2
Bangkok 2
Belgrade 2
Bitonto 2
Bolzano 2
Brescia 2
Brisbane 2
Bromley 2
Broomfield 2
Brugherio 2
Brusciano 2
Cabuyao 2
Campi Bisenzio 2
Candiac 2
Totale 1.585
Nome #
Emotional reactivity in chronic schizophrenia: structural and functional brain correlates and the influence of adverse childhood experiences 109
Valutazione del funzionamento cognitivo ‘trasferibili’ alla pratica clinica: la brief assessment of cognition scale (BACS) e la schizophrenia cognition rating scale (SCORS) 57
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes 55
Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia 49
M51. EFFICACY OF “PRAGMACOM TRAINING” IN SCHIZOPHRENIA: A RCT ON A NOVEL PRAGMATIC INTERVENTION 49
'Theory' of mind impairment in patients affected by schizophrenia and in their parents 43
Cogpack®: presupposti, descrizione e metodi a confronto",La riabilitazione cognitiva della schizofrenia 42
The cognitive architecture of verbal humor in schizophrenia 35
It is time to address language disorders in schizophrenia: a RCT on the efficacy of a novel training targeting the pragmatics of communication (PragmaCom) 32
Cognitive Remediation for Inpatients With Schizophrenia: Effects of a Brief and Intensive Training 30
Targeting quality of life in schizophrenia: the fil rouge between metabolic syndrome and anxiety 29
Cogpack®: prove di efficacia,La riabilitazione cognitiva della schizofrenia 29
Modeling the interplay of age at onset and sex on cognition in Schizophrenia 28
Communicative-pragmatic abilities mediate the relationship between cognition and daily functioning in schizophrenia 28
Interleukin-1 beta, cognition and metabolic syndrome in schizophrenia 27
Psicopatologia e semeiotica della depressione: strumenti di valutazione 27
The brief assessment of cognition in schizophrenia. Normative data for the Italian population 27
Targeting social cognition to improve functional outcome of patients with schizophrenia: Clinical evidences 26
M202. SEX-RELATED DIFFERENCES IN CLOZAPINE SIDE EFFECTS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA 26
Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex 26
Get up! Functional mobility and metabolic syndrome in chronic schizophrenia: Effects on cognition and quality of life 26
Organic Mental Disorders and Psychiatric Issues in the Elderly 25
The role of agency in schizophrenia: A pilot study on gaze agency 25
Adult Consequences of Neurodevelopmental Disorders 24
Clozapine to N-Desmethylclozapine ratio in treatment resistant schizophrenia: clinical implications from psychopathology to cognition 24
Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling 24
Disentangling Cognitive Heterogeneity in Psychotic Spectrum Disorders 24
Cognitive reserve profiles are associated with outcome in schizophrenia 21
ANTIPSYCHOTIC-INDUCED TARDIVE-DYSKINESIA - RECOGNITION, PREVENTION AND MANAGEMENT 21
Basi biologiche e trattamento della schizofrenia e del disturbo delirante 21
Amygdala and the anterior cingulate in the emotional processing in bipolar disorder and schizophrenia. A 3.0 tesla BOLD fMRI study. XXVI Congress of the Collegium Internationale Neuro-Psychopharmacologicum (CINP), Munich 13-17 July. 21
Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives 21
Amygdala and the anterior cyngulate in the emotional processing in bipolar disorder and schizophrenia. A 3.0 tesla bold FMRI study 21
Cabergoline treatment of risperidone-induced hyperprolactinemia: A pilot study 20
Adverse childhood experiences influence the detrimental effect of bipolar disorder and schizophrenia on cortico-limbic grey matter volumes 20
A leopard cannot change its spots: A novel pragmatic account of concretism in schizophrenia 20
Psychotic Disorders 19
Factors affecting cognitive remediation outcome in schizophrenia: The role of treatment resistance 19
ADDing a piece to the puzzle of cognition in schizophrenia 19
Influence of catechol-O-methyltransferase Val(158) Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia 19
S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY 19
Obesity influences white matter integrity in schizophrenia 19
Obsessive-compulsive symptoms moderates the effects of cognitive functioning on quality of life in clozapine-treated schizophrenia 18
Cognitive remediation in schizophrenia: What happens after 10 years? 18
Haloperidol metabolism and antipsychotic effect in schizophrenia 18
Catechol-O-methyltransferase and saitohin gene polymorphism interaction: Effect on executive functions in schizophrenia 18
Catechol-O-methyltransferase (COMT) genotype biases neural correlates of empathy and perceived personal distress in schizophrenia 18
VALUTAZIONI DEL FUNZIONAMENTO COGNITIVO “TRASFERIBILI” ALLA PRATICA CLINICA: LA BRIEF ASSESSMENT OF COGNITION SCALE (BACS) E LA SCHIZOPHRENIA COGNITION RATING SCALE (SCORS) 18
Achieving recovery in patients with schizophrenia through psycho-social interventions: A retrospective study 18
Cognition in Schizophrenia: Modeling the Interplay between Interleukin-1β C-511T Polymorphism, Metabolic Syndrome, and Sex 18
Deconstructing heterogeneity in schizophrenia through language: a semi-automated linguistic analysis and data-driven clustering approach 17
Non-Pharmacological Treatments 17
Factors affecting the clinical response to haloperidol therapy in schizophrenia. 17
9-OH risperidone response in risperidone poor responders: An open study of drug response concordance 17
Antiprostatic effect of cimetidine in rats. 17
Unmet needs in the treatment of schizophrenia: The role of aripiprazole [Bisogni irrisolti nel trattamento della schizofrenia: Ruolo di aripiprazolo] 17
Association study of COMT Val108/158Met polymorphism and treatment response to haloperidol, risperidone and clozapine 17
Dialectical Behavior Therapy Skills Training in Alcohol Dependence Treatment: Findings Based on an Open Trial. 17
On the Implementation of Computerized Adaptive Observations for Psychological Assessment 17
Longitudinal course of cognition in schizophrenia: Does treatment resistance play a role? 17
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art 17
Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study 16
Daily Functioning in Schizophrenia: Is There Room for Anxiety? 16
Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-beta activity 16
The Influence of Premorbid Adjustment and Autistic Traits on Social Cognitive Dysfunction in Schizophrenia 16
Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity 16
Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy 16
Is longer treatment better? A comparison study of 3 versus 6 months cognitive remediation in schizophrenia 16
White matter integrity, clinical symptoms and quality of life in schizophrenia: a DTI study 15
HTTLPR functional polymorphism in schizophrenia: Executive functions vs. sustained attention dissociation 15
Extrapyramidal collateral effects induced by neuroleptic agents. II. Acute extrapyramidal effects [GLI EFFETTI COLLATERALI EXTRAPIRAMIDALI INDOTTI DA NEUROLETTICI. II: GLI EFFETTI EXTRAPIRAMIDALI ACUTI] 15
Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement. 15
Association study of GSK-3 beta-50T/C polymorphism with haloperidol resistance in schizophrenia. 15
The treatment of resistant schizophrenia: a pilot, open study on the treatment with risperidone and clozapine. 15
Pragmatic abilities across symptoms dimensions in schizophrenia 15
Brand-name versus generic clozapine for the treatment of resistant schizophrenia: Bioequivalence and interchangeability issues [Clozapina «brand» e clozapina generica nel trattamento della schizofrenia farmacoresistente: Bioequivalenza ed intercambiabilità] 15
Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: Persistence after 5years 15
The role of premorbid adjustment in schizophrenia: Focus on cognitive remediation outcome 15
The comprehension of idiomatic expressions in schizophrenic patients 14
A PILOT, OPEN STUDY ON THE TREATMENT OF REFRACTORY SCHIZOPHRENIA WITH RISPERIDONE AND CLOZAPINE 14
SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects. 14
Medium-term effectiveness of a new, prolonged-release, atypical antipsychotic: An objectives-based observational study [Effectiveness a medio termine di un nuovo antipsicotico atipico a rilascio prolungato: Uno studio osservazionale per obbiettivi] 14
Factors affecting cognitive remediation response in schizophrenia: The role of COMT gene and antipsychotic treatment 14
Effect of 5-HT1a and catechol-O-methyltransferase gene polymorphisms on negative symptom response to clozapine 14
Source monitoring deficits in schizophrenia: A signal detection analysis study 14
Prolactin concentrations after single and repeated oral doses of savoxepine in patients with chronic schizophrenia 14
Computer-aided neurocognitive remediation in schizophrenia: Durability of rehabilitation outcomes in a follow-up study 14
Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia 14
Shared reduction of oscillatory natural frequencies in bipolar disorder, major depressive disorder and schizophrenia 14
Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study 14
Words toward recovery: analyzing speech determinants of quality of life in chronic schizophrenia 14
Belief Inflexibility and Cognitive Biases in Anorexia Nervosa—The Role of the Bias against Disconfirmatory Evidence and Its Clinical and Neuropsychological Correlates 13
Smooth pursuit eye movements and saccadic eye movements in patients with delusional disorder 13
Effect of glutamate transporter EAAT2 gene variants and gray matter deficits on working memory in schizophrenia 13
A functional comparison of patients with schizophrenia between the North and South of Europe 13
Neuroleptic-induced extrapyramidal side effects. I: Tardive dyskinesia [GLI EFFETTI COLLATERALI EXTRAPIRAMIDALI INDOTTI DA NEUROLETTICI. I: LA DISCINESIA TARDIVA] 13
Obsessive compulsive disorder among idiopathic focal dystonia patients: An epidemiological and family study 13
Amygdala and the anterior cingulate in the emotional processing in bipolar disorder and schizophrenia. A 3.0 tesla BOLD fMRI study. 13
Self-awareness of cognitive functioning in schizophrenia: patients and their relatives 13
PREVALENCE AND SEVERITY OF NEUROLEPTIC-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS IN SCHIZOPHRENIA AND DELUSIONAL DISORDER - RELATIONSHIPS WITH DIAGNOSIS 13
Totale 2.138
Categoria #
all - tutte 54.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 1 1 0 0 0 1 0 0
2020/202115 0 0 0 0 0 10 3 0 0 2 0 0
2021/2022149 0 0 0 41 20 9 9 12 16 9 15 18
2022/20231.362 495 256 87 15 47 172 51 95 70 26 21 27
2023/2024789 53 47 87 72 81 131 20 71 6 30 54 137
2024/2025857 451 94 76 169 67 0 0 0 0 0 0 0
Totale 3.235